Floatz logo

16 assets in Coronary Artery Disorder

Therapeutic assets addressing Coronary Artery Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Aspirin
Coronary Artery Disorder
Rajaie Cardiovascular Medical and Research CenterP4BBB (79)
Rivaroxaban
Coronary Artery Disorder
Sheffield Teaching Hospitals NHS Foundation TrustP4BBB (75)
Clopidogrel
Coronary Artery Disorder
Beijing Tiantan HospitalP4BB (70)
Edoxaban
Coronary Artery Disorder
St. Antonius HospitalP4BB (68)
Mazdutide
Coronary Artery Disorder
China National Center for Cardiovascular DiseasesP4BB (65)
Tirzepatide
Coronary Artery Disorder
JULIO GRANADOS MONTIELP4BB (65)
Ticagrelor
Coronary Artery Disorder
Assistance Publique - Hôpitaux de ParisP3BB (64)
Colchicinum
Coronary Artery Disorder
Assistance Publique - Hôpitaux de ParisP3B (60)
A Replication-Deficient Recombinant Adenovirus, Serotype 5, Encoding Multiple Human Vascular Endothelial Growth Factor (Vegf) Isoforms
Coronary Artery Disorder
XyloCor Therapeutics, Inc.P2CCC (53)
Aux-001
Coronary Artery Disorder
Auxilius Pharma sp.z.o.o.Early P1C (39)
Byetta
Coronary Artery Disorder
Rigshospitalet, DenmarkN/AD (30)
Exenatide
Coronary Artery Disorder
Rigshospitalet, DenmarkN/AD (30)
Normal Human Serum Albumin
Coronary Artery Disorder
Rigshospitalet, DenmarkN/AD (30)
Oxygen
Coronary Artery Disorder
Rigshospitalet, DenmarkN/AD (30)
Atorvastatin
Coronary Artery Disorder
University of Texas Southwestern Medical CenterP4NR ()